Form 8-K - Current report:
SEC Accession No. 0001104659-24-095203
Filing Date
2024-08-30
Accepted
2024-08-30 07:05:21
Documents
13
Period of Report
2024-08-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2423046d1_8k.htm   iXBRL 8-K 29868
  Complete submission text file 0001104659-24-095203.txt   203587

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA trvn-20240828.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvn-20240828_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvn-20240828_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2423046d1_8k_htm.xml XML 3675
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36193 | Film No.: 241265928
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)